Citywire for Financial Professionals

Woodford Patient Capital Trust (Ordinary Share) WPCT

UK Growth

Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Add to Virtual Portfolio | Print page

Estimated NAV

100.00

Share Price

N/A

Total Returns on £1000 over 

Fund / Benchmark Total returns(%)
Woodford Patient Capital Trust (Ordinary Share) Price -1.57%
Woodford Patient Capital Trust (Ordinary Share) NAV 4.52%
FTSE All-Share Index 11.49%
Total Returns on £1000

Discount / Premium Movement

Discount / Premium Movement

Shares

Share Type Yesterday's
Closing Price
Discount / Premium Diluted NAV Gearing Dividend
Est Last
Ordinary Share 95.8 -4.6% 100.00 101.00
18 Sep
112% 0.25%

Discrete performance % over

Fund / BenchmarkQ1Q2Q3Q4
Woodford Patient Capital Trust (Ordinary Share) Price-1.57
Woodford Patient Capital Trust (Ordinary Share) NAV4.52
FTSE All-Share Index11.49

Discrete performance over

Discrete Performance

Top 10 Holdings

Prothena Corp PLC 12.22%
Purplebricks Group PLC 9.31%
Oxford Nanopore Technologies 7.37%
Immunocore A 6.27%
Theravance Biopharma Inc 5.03%
Proton Partners International 3.52%
Mereo Bipharma 3.46%
Oxford Science Innovations 2.82%
Atom Bank 2.41%
Gigaclear 2.30%

Sectors weighting

Healthcare 66.70%
Finance - General 32.00%
Technology 7.10%
General Industrials 6.40%
Telecommunications 2.70%
Consumer Goods 1.90%
Materials 0.30%
Cash/Cash Equivalent -17.00%

Regional weighting

UK 71.00%
Europe Developed ex-UK 21.00%
North America Region 8.00%
  • Investment trust info:

  • Sector UK Growth
  • Launch Date 21 Apr 2015
  • Currency GBX
  • Domicile UK
  • Share Price N/A
  • Share Type Ordinary Share
  • TIDM WPCT
  • ISIN GB00BVG1CF25
  • Shares Issued (M) 827
  • Market Capital (£M) 791.85
  • Gross Assets (£M) 931.87
  • Net Assets (£M) 829.86
  • TER (%) 0.15
  • Historic Dividend Yield (%) 0.25
  • Last AGM 12 Jun 2017
  • Next AGM 12 Jun 2018
  • Last Annual Report Date 27 Jul 2017
  • Next due Report Date 30 Jun 2017
  • Next due Report Type I/R
  • Objective:

  • To achieve long-term capital growth through investing in a diversified portfolio with a focus on UK companies, both quoted and unquoted. The company will aim to deliver a return in excess of 10% p.a. over the longer term.
  • Management Group(s):

  • Woodford Investment Management Ltd
  • Managed by:

  • Neil Woodford Start: 21 Apr 2015
  • Paul Lamacraft Start: 21 Apr 2015
  • Saku Saha Start: 21 Apr 2015
  • Stephen Lamacraft Start: 21 Apr 2015
  • Management Contract & Fees:

    Woodford Investment Management does not receive a management fee from the Company for its services and is only awarded a fee based on performance. The performance fee equals to 15% of any excess returns over a 10% hurdle rate per annum, subject to a high watermark. The majority of any performance fee is payable in Ordinary shares.

Sorry, this link is not
quite ready yet